CYP17A1 and metabolic syndrome: Because CYP17A1 is involved in steroidogenesis and earlier studies have shown that changes in sex hormones are associated with insulin resistance [35–38], we conducted a series of assays to investigate the effect of its deficiency on metabolic syndrome.